Mar. 21, 2019
Bioceres, which sells biologic agrochemicals and develops seed productivity traits in Argentina, officially withdrew its plans for an initial public offering on Friday following its merger with a publicly-traded blank check company.
Bioceres had originally set terms for an IPO in February 2018 that would have raised $130 million at a market cap of $497 million, but postponed the deal; it later announced in November 2018 that it would be acquired by SPAC Union Acquisition. The merger was completed on Thursday, and the new company, Bioceres Crop Solutions, began trading on the NYSE on Friday under the symbol BIOX.